Pure Global

Vibrotactile Stimulation With Saphenus Device - Trial NCT05961072

Access comprehensive clinical trial information for NCT05961072 through Pure Global AI's free database. This phase not specified trial is sponsored by Massachusetts General Hospital and is currently Not yet recruiting. The study focuses on Amputation. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05961072
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT05961072
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Vibrotactile Stimulation With Saphenus Device
Vibrotactile Stimulation for Improved Gait and Pain After Major Lower Extremity Amputation Using a Non-invasive Vibration Device

Study Focus

Amputation

Vibrotactile sensory feedback device

Interventional

device

Sponsor & Location

Massachusetts General Hospital

Boston, United States of America

Timeline & Enrollment

N/A

Aug 01, 2023

May 01, 2024

50 participants

Primary Outcome

Measure Velocity,Measure Endurance,Measure Physical Function,Measure User Satisfaction of Function,Measure Pain Overall,Measure Pain Interference,Measure Pain Intensity

Summary

To determine the benefit of the vvibrotactile sensory feedback device.

ICD-10 Classifications

Amputation of limb(s)
Traumatic amputation of both feet
Traumatic amputation of upper and lower limbs, any combination [any level]
Traumatic amputations involving other combinations of body regions
Traumatic amputation of lower leg

Data Source

ClinicalTrials.gov

NCT05961072

Device Trial